Tag | Content |
---|
EnhancerAtlas ID | HS108-24398 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr2:231304310-231305190 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr2:231304713-231304731 | GAAAGGAAAGAAGGAAGG | + | 7.97 | EWSR1-FLI1 | MA0149.1 | chr2:231304721-231304739 | AGAAGGAAGGAAGGAAAG | + | 8.46 | EWSR1-FLI1 | MA0149.1 | chr2:231304725-231304743 | GGAAGGAAGGAAAGAAAG | + | 8.46 | EWSR1-FLI1 | MA0149.1 | chr2:231304717-231304735 | GGAAAGAAGGAAGGAAGG | + | 9.47 | LMX1B | MA0703.2 | chr2:231305157-231305168 | AATTTAATTAA | + | 6.32 | LMX1B | MA0703.2 | chr2:231305160-231305171 | TTAATTAAATT | - | 6.32 | PHOX2A | MA0713.1 | chr2:231305161-231305172 | TAATTAAATTA | - | 6.62 | PROP1 | MA0715.1 | chr2:231305161-231305172 | TAATTAAATTA | + | 6.32 | PROP1 | MA0715.1 | chr2:231305161-231305172 | TAATTAAATTA | - | 6.62 | Phox2b | MA0681.1 | chr2:231305161-231305172 | TAATTAAATTA | - | 6.62 | SPIC | MA0687.1 | chr2:231304559-231304573 | GACTTCCTGTTTTA | - | 6.14 | ZNF263 | MA0528.1 | chr2:231304722-231304743 | GAAGGAAGGAAGGAAAGAAAG | + | 6.03 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_09384 | chr2:231304023-231305429 | CD14 | SE_10266 | chr2:231304224-231307763 | CD19_Primary | SE_10885 | chr2:231272649-231341656 | CD20 | SE_18487 | chr2:231303674-231309186 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19844 | chr2:231304274-231307101 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_22757 | chr2:231304079-231308972 | CD8_primiary | SE_62343 | chr2:231275151-231339482 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I230439 | chr2 | 231303941 | 231304959 |
|
Enhancer Sequence | TATTTTTTAT TTATTTATTT TTTTGCAGCT GTTGTAAAAG GGATTTGATT TGATTCTCAG 60 CTTGATCATT GTTGGTGTAT AGCAGTGCTA CTTATGATTT TGTATCCTGA AACTTAACTG 120 AATTCATTTA TCAGATCTAT ATCTTAGGAT ACTAATCATA TCATTGGTGA ACAGTGACTC 180 AAGTTTGACT TCCTCTTTAC CGATTAGGAT GCCCTTTATT TCTTTCTTTT GTCTGACTGC 240 TCGGGCTAGG ACTTCCTGTT TTATCTTTTA CAACTCATTG TTTCCCTTGT TTTATCTCTC 300 TAAAAATGCA AACTATGTCT GCTTTTTATT TTTATTTTCA GTGTTACATA AGGTTTTATA 360 AGGTCTGATT TCACTCAATC AGTAGTTATT TTCAAATCTT TTCGAAAGGA AAGAAGGAAG 420 GAAGGAAAGA AAGACGCAGG AATATGTATA AAGGTATAGC AAACATCACA CTTAATGGTG 480 CTGCTAAGTG CTTCTTCCTT GAAATTGGAA ATAAGGCAAG GAAGTCCACT CTCATCACTT 540 CTCTTCAACA TTGTATTCAA ACTCCTAACC AGTGAAATGA GACCAAAAAA TAGAAATAAT 600 TGTTTGGAAA GAAACAGTAA GTCAGTCTAT TTGTTCATGA TATAATTATT TTCTTTAAAA 660 TACAAAGGAA ATCTATAAAT AATTTACTAG AAATACTACA TGAATTTAGC AATGCCATAA 720 ATTCATGGTT AATATGTTTC AAACCAATTA TATTTTCATA TAATAGTAAT AAGGAATTTG 780 AAAAGCATTA TCATTTAAAG TAACACCAAA ACAATAAAAT AACTAGGAAT AAATTTATTA 840 TTTTTTAAAT TTAATTAAAT TAAATTTTTT ATTTCAATAG 880
|